These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 23115324)

  • 1. BET bromodomain proteins mediate downstream signaling events following growth factor stimulation in human lung fibroblasts and are involved in bleomycin-induced pulmonary fibrosis.
    Tang X; Peng R; Ren Y; Apparsundaram S; Deguzman J; Bauer CM; Hoffman AF; Hamilton S; Liang Z; Zeng H; Fuentes ME; Demartino JA; Kitson C; Stevenson CS; Budd DC
    Mol Pharmacol; 2013 Jan; 83(1):283-93. PubMed ID: 23115324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Brd4 inhibition in idiopathic pulmonary fibrosis lung fibroblasts and in vivo models of lung fibrosis.
    Tang X; Peng R; Phillips JE; Deguzman J; Ren Y; Apparsundaram S; Luo Q; Bauer CM; Fuentes ME; DeMartino JA; Tyagi G; Garrido R; Hogaboam CM; Denton CP; Holmes AM; Kitson C; Stevenson CS; Budd DC
    Am J Pathol; 2013 Aug; 183(2):470-9. PubMed ID: 23759512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inhibitory effect of ginsan on TGF-β mediated fibrotic process.
    Ahn JY; Kim MH; Lim MJ; Park S; Lee SL; Yun YS; Song JY
    J Cell Physiol; 2011 May; 226(5):1241-7. PubMed ID: 20945375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CG223, a novel BET inhibitor, exerts TGF-β1-mediated antifibrotic effects in a murine model of bleomycin-induced pulmonary fibrosis.
    Kaneshita S; Kida T; Yoshioka M; Nishioka K; Raje M; Sakashita A; Hirano A; Sagawa T; Kasahara A; Inoue T; Fujioka K; Nagahara H; Wada M; Kohno M; Strovel JW; Fletcher S; Ashihara E; Kawahito Y
    Pulm Pharmacol Ther; 2021 Oct; 70():102057. PubMed ID: 34425215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen.
    Ponticos M; Holmes AM; Shi-wen X; Leoni P; Khan K; Rajkumar VS; Hoyles RK; Bou-Gharios G; Black CM; Denton CP; Abraham DJ; Leask A; Lindahl GE
    Arthritis Rheum; 2009 Jul; 60(7):2142-55. PubMed ID: 19565505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis.
    Wang XM; Zhang Y; Kim HP; Zhou Z; Feghali-Bostwick CA; Liu F; Ifedigbo E; Xu X; Oury TD; Kaminski N; Choi AM
    J Exp Med; 2006 Dec; 203(13):2895-906. PubMed ID: 17178917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of prosurvival signaling in fibroblasts by a protein kinase inhibitor protects against fibrotic tissue injury.
    Vittal R; Horowitz JC; Moore BB; Zhang H; Martinez FJ; Toews GB; Standiford TJ; Thannickal VJ
    Am J Pathol; 2005 Feb; 166(2):367-75. PubMed ID: 15681821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant soluble ectodomain of fibroblast growth factor receptor-2 IIIc attenuates bleomycin-induced pulmonary fibrosis in mice.
    Yu ZH; Wang DD; Zhou ZY; He SL; Chen AA; Wang J
    Biol Pharm Bull; 2012; 35(5):731-6. PubMed ID: 22687409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brd4-p300 inhibition downregulates Nox4 and accelerates lung fibrosis resolution in aged mice.
    Sanders YY; Lyv X; Zhou QJ; Xiang Z; Stanford D; Bodduluri S; Rowe SM; Thannickal VJ
    JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32544088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase inhibitor restores surfactant protein-C expression in alveolar-epithelial type II cells and attenuates bleomycin-induced pulmonary fibrosis in vivo.
    Ota C; Yamada M; Fujino N; Motohashi H; Tando Y; Takei Y; Suzuki T; Takahashi T; Kamata S; Makiguchi T; Yamaya M; Kubo H
    Exp Lung Res; 2015; 41(8):422-34. PubMed ID: 26151196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effect of a peptide inhibitor of TGF-β on pulmonary fibrosis.
    Arribillaga L; Dotor J; Basagoiti M; Riezu-Boj JI; Borrás-Cuesta F; Lasarte JJ; Sarobe P; Cornet ME; Feijoó E
    Cytokine; 2011 Mar; 53(3):327-33. PubMed ID: 21185199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thalidomide prevents bleomycin-induced pulmonary fibrosis in mice.
    Tabata C; Tabata R; Kadokawa Y; Hisamori S; Takahashi M; Mishima M; Nakano T; Kubo H
    J Immunol; 2007 Jul; 179(1):708-14. PubMed ID: 17579094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological targeting of BET proteins attenuates radiation-induced lung fibrosis.
    Wang J; Zhou F; Li Z; Mei H; Wang Y; Ma H; Shi L; Huang A; Zhang T; Lin Z; Wu G
    Sci Rep; 2018 Jan; 8(1):998. PubMed ID: 29343723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced endogenous bone morphogenetic protein signaling protects against bleomycin induced pulmonary fibrosis.
    De Langhe E; Cailotto F; De Vooght V; Aznar-Lopez C; Vanoirbeek JA; Luyten FP; Lories RJ
    Respir Res; 2015 Mar; 16(1):38. PubMed ID: 25849157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Wnt/β-catenin signaling suppresses bleomycin-induced pulmonary fibrosis by attenuating the expression of TGF-β1 and FGF-2.
    Chen X; Shi C; Meng X; Zhang K; Li X; Wang C; Xiang Z; Hu K; Han X
    Exp Mol Pathol; 2016 Aug; 101(1):22-30. PubMed ID: 27112840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitogen-activated Protein Kinase-activated Protein Kinase 2 Inhibition Attenuates Fibroblast Invasion and Severe Lung Fibrosis.
    Liang J; Liu N; Liu X; Mena JM; Xie T; Geng Y; Huan C; Zhang Y; Taghavifar F; Huang G; Kurkciyan A; Barron V; Jiang D; Noble PW
    Am J Respir Cell Mol Biol; 2019 Jan; 60(1):41-48. PubMed ID: 30130411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic Chromatin Targeting of BRD4 Stimulates Cardiac Fibroblast Activation.
    Stratton MS; Bagchi RA; Felisbino MB; Hirsch RA; Smith HE; Riching AS; Enyart BY; Koch KA; Cavasin MA; Alexanian M; Song K; Qi J; Lemieux ME; Srivastava D; Lam MPY; Haldar SM; Lin CY; McKinsey TA
    Circ Res; 2019 Sep; 125(7):662-677. PubMed ID: 31409188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological targeting of BET proteins inhibits renal fibroblast activation and alleviates renal fibrosis.
    Xiong C; Masucci MV; Zhou X; Liu N; Zang X; Tolbert E; Zhao TC; Zhuang S
    Oncotarget; 2016 Oct; 7(43):69291-69308. PubMed ID: 27732564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of bleomycin-induced pulmonary fibrosis by a novel antifibrotic peptide with relaxin-like activity.
    Pini A; Shemesh R; Samuel CS; Bathgate RA; Zauberman A; Hermesh C; Wool A; Bani D; Rotman G
    J Pharmacol Exp Ther; 2010 Dec; 335(3):589-99. PubMed ID: 20826567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-fibrotic effects of microRNA-153 by targeting TGFBR-2 in pulmonary fibrosis.
    Liang C; Li X; Zhang L; Cui D; Quan X; Yang W
    Exp Mol Pathol; 2015 Oct; 99(2):279-85. PubMed ID: 26216407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.